Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer
1 clinical trials · Condition
◉ Watch Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC） (NCT06505837) | Shanghai Junshi Bioscience Co., Ltd. | 2024-07-11 |
Track Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.